Free Trial

Prelude Therapeutics (PRLD) Institutional Ownership

Prelude Therapeutics logo
$3.66 +0.16 (+4.57%)
Closing price 04:00 PM Eastern
Extended Trading
$3.66 0.00 (0.00%)
As of 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Prelude Therapeutics (NASDAQ:PRLD)

Current
Institutional Ownership
Percentage
79.72%
Number of
Institutional Buyers
(last 12 months)
17
Total
Institutional Inflows
(last 12 months)
$7.73M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$4.37M
Get PRLD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Prelude Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PRLD Institutional Buying and Selling by Quarter

Prelude Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE56,525$193K0.0%+476.3%0.090%
5/18/2026 ADAR1 Capital Management LLC152,825$523K0.0%N/A0.243%
5/18/2026 EcoR1 Capital LLC947,049$3.24M0.1%N/A1.503%
5/15/2026 OMERS ADMINISTRATION Corp32,700$112K0.0%-55.2%0.052%
5/14/2026 Renaissance Technologies LLC275,200$941K0.0%+1.4%0.437%
5/7/2026 Dimensional Fund Advisors LP35,210$120K0.0%N/A0.056%
2/18/2026 XTX Topco Ltd50,159$145K0.0%+222.0%0.080%
2/18/2026 Sphera Funds Management LTD.122,752$356K0.1%N/A0.195%
2/18/2026 Millennium Management LLC150,997$438K0.0%-86.8%0.240%
2/17/2026 Price T Rowe Associates Inc. MD755,956$2.19M0.0%-13.7%1.202%
2/16/2026 OMERS ADMINISTRATION Corp73,000$212K0.0%N/A0.116%
2/13/2026 Marshall Wace LLP273,883$794K0.0%N/A0.436%
2/13/2026 State Street Corp127,292$369K0.0%+30.4%0.202%
2/12/2026 Jane Street Group LLC111,040$322K0.0%+218.9%0.177%
2/12/2026 Renaissance Technologies LLC271,300$787K0.0%-50.1%0.432%
2/10/2026 Goldman Sachs Group Inc.117,477$341K0.0%+48.1%0.187%
2/9/2026 Geode Capital Management LLC272,886$792K0.0%+25.4%0.434%
11/17/2025 Millennium Management LLC1,147,044$1.65M0.0%+361.7%1.824%
11/14/2025 Shay Capital LLC100,000$144K0.0%+33.3%0.177%
11/14/2025 Bridgeway Capital Management LLC53,500$77K0.0%-39.5%0.095%
11/7/2025Vanguard Group Inc.992,854$1.43M0.0%+6.5%1.754%
8/15/2025 Shay Capital LLC75,000$61K0.0%N/A0.133%
8/14/2025 Jane Street Group LLC91,753$74K0.0%N/A0.163%
8/13/2025 Marshall Wace LLP41,747$34K0.0%N/A0.074%
8/12/2025 XTX Topco Ltd42,573$34K0.0%+72.4%0.075%
8/8/2025 Geode Capital Management LLC217,568$176K0.0%-46.3%0.385%
8/1/2025 Y Intercept Hong Kong Ltd47,788$39K0.0%N/A0.085%
5/21/2025Acadian Asset Management LLC529,327$405K0.0%+9.1%0.938%
5/16/2025AQR Capital Management LLC33,823$26K0.0%+170.7%0.078%
5/12/2025Simplex Trading LLC41,846$32K0.0%+121.2%0.096%
5/9/2025Deutsche Bank AG80,723$62K0.0%-34.8%0.185%
2/17/2025Two Sigma Investments LP231,839$296K0.0%+307.2%0.421%
2/17/2025Two Sigma Advisers LP300,000$382K0.0%+526.3%0.545%
2/17/2025Millennium Management LLC462,555$590K0.0%+188.2%0.841%
2/17/2025Jacobs Levy Equity Management Inc.666,574$850K0.0%+280.9%1.211%
2/17/2025Deutsche Bank AG123,899$159K0.0%+747.6%0.225%
2/17/2025Bridgeway Capital Management LLC111,000$142K0.0%-37.0%0.202%
2/17/2025BNP Paribas Financial Markets20,572$26K0.0%N/A0.037%
2/14/2025Boxer Capital Management LLC1,708,187$2.18M0.2%N/A3.104%
2/14/2025Northern Trust Corp83,387$106K0.0%-21.6%0.152%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
2/14/2025Price T Rowe Associates Inc. MD1,029,199$1.31M0.0%-6.2%1.870%
2/13/2025Marshall Wace LLP392,155$498K0.0%+9.2%0.713%
2/13/2025Renaissance Technologies LLC634,500$809K0.0%+222.2%1.153%
2/12/2025Massachusetts Financial Services Co. MA494,497$630K0.0%-10.0%0.899%
2/12/2025JPMorgan Chase & Co.61,149$78K0.0%+925.0%0.111%
2/6/2025Charles Schwab Investment Management Inc.117,200$149K0.0%-12.0%0.213%
1/30/2025Rhumbline Advisers166,830$213K0.0%+1,289.8%0.303%
11/19/2024Barclays PLC27,165$57K0.0%+86.0%0.049%
11/16/2024Geode Capital Management LLC391,716$811K0.0%+8.2%0.712%
11/15/2024Barclays PLC27,165$57K0.0%+86.0%0.049%
11/15/2024XTX Topco Ltd48,239$100K0.0%N/A0.088%
11/15/2024State Street Corp286,046$592K0.0%+35.1%0.520%
11/15/2024Jacobs Levy Equity Management Inc.174,979$362K0.0%+885.2%0.318%
11/14/2024Walleye Capital LLC83,175$172K0.0%+446.2%0.151%
11/12/2024Massachusetts Financial Services Co. MA549,530$1.14M0.0%+5.2%0.999%
10/10/2024Exchange Traded Concepts LLC64,409$133K0.0%+32.2%0.153%
8/15/2024The Manufacturers Life Insurance Company70,045$267K0.0%-3.1%0.166%
8/9/2024Renaissance Technologies LLC206,600$787K0.0%-15.6%0.491%
8/9/2024Dimensional Fund Advisors LP29,074$111K0.0%+103.2%0.069%
8/9/2024Massachusetts Financial Services Co. MA522,375$1.99M0.0%+2.8%1.241%
7/26/2024Bank of New York Mellon Corp36,276$138K0.0%-9.5%0.086%
5/16/2024Kennedy Capital Management LLC25,035$119K0.0%N/A0.059%
5/15/2024Price T Rowe Associates Inc. MD941,971$4.47M0.0%-9.7%2.239%
5/10/2024Acadian Asset Management LLC22,110$104K0.0%+42.7%0.053%
5/10/2024Vanguard Group Inc.1,016,999$4.82M0.0%+1.0%2.417%
2/15/2024Boxer Capital LLC2,568,287$10.97M0.5%+2.9%4.684%
2/14/2024Pale Fire Capital SE63,581$271K0.0%+106.6%0.116%
1/12/2024SG Americas Securities LLC13,100$56K0.0%N/A0.024%
1/5/2024Exchange Traded Concepts LLC44,087$188K0.0%+34.0%0.080%
11/14/2023Pale Fire Capital SE30,781$95K0.0%N/A0.056%
11/13/2023FMR LLC5,131,433$15.86M0.0%-13.6%9.359%
11/7/2023Barclays PLC13,316$42K0.0%+120.0%0.024%
10/27/2023TD Asset Management Inc160,652$496K0.0%+100.0%0.293%
10/18/2023Exchange Traded Concepts LLC32,907$102K0.0%+29.4%0.060%
9/21/2023Barclays PLC6,052$27K0.0%-41.4%0.011%
8/15/2023Boxer Capital LLC2,495,018$11.23M0.5%+256.9%4.552%
8/9/2023TD Asset Management Inc80,326$361K0.0%+182.4%0.147%
7/20/2023Exchange Traded Concepts LLC25,428$114K0.0%N/A0.053%
5/16/2023Boxer Capital LLC699,047$3.99M0.2%N/A1.458%
5/1/2023Virtu Financial LLC11,201$64K0.0%N/A0.023%
2/14/2023683 Capital Management LLC28,631$173K0.0%N/A0.060%
2/13/2023GSA Capital Partners LLP47,801$289K0.0%-11.8%0.100%
2/10/2023New York Life Investment Management LLC82,000$495K0.0%+11.7%0.171%
2/9/2023Citigroup Inc.60,072$363K0.0%+604.1%0.126%
2/7/2023Bleakley Financial Group LLC22,325$135K0.0%N/A0.047%
11/15/2022Caxton Associates LP85,992$568K0.1%+2.5%0.180%
11/14/2022PDT Partners LLC12,641$84K0.0%-71.1%0.026%
11/9/2022Massachusetts Financial Services Co. MA513,293$3.39M0.0%+7.3%1.073%
10/25/2022Denali Advisors LLC8,200$54K0.0%N/A0.017%
8/16/2022Corton Capital Inc.15,586$81K0.1%+42.8%0.033%
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

8/16/2022Delphia USA Inc.16,940$88K0.1%N/A0.035%
8/13/2022Massachusetts Financial Services Co. MA478,525$2.50M0.0%-0.7%1.000%
8/12/2022Virtus ETF Advisers LLC24,005$125K0.0%+84.0%0.050%
7/19/2022Commonwealth Equity Services LLC16,617$86K0.0%-18.8%0.035%
5/11/2022Massachusetts Financial Services Co. MA482,119$3.33M0.0%+2.8%1.012%
5/11/2022GSA Capital Partners LLP23,201$160K0.0%N/A0.049%
5/6/2022IndexIQ Advisors LLC56,750$392K0.0%N/A0.119%
5/5/2022New York State Common Retirement Fund4,992$34K0.0%-45.1%0.010%
5/4/2022Commonwealth Equity Services LLC20,467$141K0.0%-10.4%0.043%
3/3/2022Walleye Capital LLC41,954$522K0.0%N/A0.089%


PRLD Institutional Ownership - Frequently Asked Questions

During the previous two years, 38 institutional investors and hedge funds held shares of Prelude Therapeutics. The most heavily invested institutionals were EcoR1 Capital LLC ($3.24M), Price T Rowe Associates Inc. MD ($2.19M), Boxer Capital Management LLC ($2.18M), Vanguard Group Inc. ($1.43M), Renaissance Technologies LLC ($941K), Jacobs Levy Equity Management Inc. ($850K), and Marshall Wace LLP ($794K).Learn more on Prelude Therapeutics' institutional investors.

79.72% of Prelude Therapeutics' stock is owned by institutional investors. Learn more on PRLD's institutional investor holdings.

Of the 32 institutional investors that purchased Prelude Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Boxer Capital Management LLC ($1.71M), Millennium Management LLC ($1.20M), EcoR1 Capital LLC ($947.05K), Jacobs Levy Equity Management Inc. ($648.81K), Renaissance Technologies LLC ($441.50K), Marshall Wace LLP ($348.65K), and Two Sigma Advisers LP ($252.10K).

Institutional investors have bought a total of 3,147,369 shares in the last 24 months. This purchase volume represents approximately $7.73M in transactions.

The following institutional investors have sold Prelude Therapeutics stock in the last 24 months: Millennium Management LLC ($996.05K), Renaissance Technologies LLC ($272.70K), Geode Capital Management LLC ($187.39K), Price T Rowe Associates Inc. MD ($120.38K), OMERS ADMINISTRATION Corp ($40.30K), and Bridgeway Capital Management LLC ($35K).

Institutional investors have sold a total of 1,651,816 shares in the last 24 months. This volume of shares sold represents approximately $4.37M in transactions.



This page (NASDAQ:PRLD) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners